A guide for biopharma and biotechnology organizations to maximize FSP engagements–and capitalize on the latest trends–to meet their timelines.
Across the globe, drug developers continue to seek solutions for navigating the challenges associated with drug discovery – including rising costs, patient recruitment and increased complexity. Increasingly, biotech and biopharma companies are leveraging functional service provider (FSP) solutions to meet their timelines and ensure their projects stay on budget.
What’s in the report:
• The latest utilization and growth projection of FSP partnerships in the clinical research and development landscape.
• The future of innovative FSP strategies and models.
• The keys to successfully leveraging an FSP model to drive on-time, on-budget delivery
Did you know? FSP outsourcing is growing faster than full-service outsourcing (FSO). 35% of participants say they have increased FSP outsourcing, vs. 29% who have upped their use of FSO, and this trend is seen in both large and small/mid-size biopharma segments.
Offered Free by: PPD
See All Resources from: PPD
